PTC Therapeutics | PTCT - Market Capitalization

Stock Price
70.04
Daily Change
2.27 3.35%
Monthly
2.40%
Yearly
63.57%
Q2 Forecast
65.73

PTC Therapeutics reported $5.19B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Cytokinetics USD 7.77B 1.19B Dec/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Esperion Therapeutics USD 885M 351M Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Karyopharm Therapeutics USD 652M 517M Apr/2026
Novartis USD 292.21B 26.55B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025
Xencor USD 1.09B 256M Dec/2025